Literature DB >> 26359493

Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States.

Ryan Roth1, Richard Swanson1, Gonzalo Izaguirre1, Susan C Bock2, Peter G W Gettins3, Steven T Olson4.   

Abstract

Past studies have suggested that a key feature of the mechanism of heparin allosteric activation of the anticoagulant serpin, antithrombin, is the release of the reactive center loop P14 residue from a native state stabilizing interaction with the hydrophobic core. However, more recent studies have indicated that this structural change plays a secondary role in the activation mechanism. To clarify this role, we expressed and characterized 15 antithrombin P14 variants. The variants exhibited basal reactivities with factors Xa and IXa, heparin affinities and thermal stabilities that were dramatically altered from wild type, consistent with the P14 mutations perturbing native state stability and shifting an allosteric equilibrium between native and activated states. Rapid kinetic studies confirmed that limiting rate constants for heparin allosteric activation of the mutants were altered in conjunction with the observed shifts of the allosteric equilibrium. However, correlations of the P14 mutations' effects on parameters reflecting the allosteric activation state of the serpin were inconsistent with a two-state model of allosteric activation and suggested multiple activated states. Together, these findings support a minimal three-state model of allosteric activation in which the P14 mutations perturb equilibria involving distinct native, intermediate, and fully activated states wherein the P14 residue retains an interaction with the hydrophobic core in the intermediate state but is released from the core in the fully activated state, and the bulk of allosteric activation has occurred in the intermediate.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  allosteric regulation; anticoagulant; antithrombin (AT); coagulation factor; heparin; protease; protease inhibitor; serine protease; serpin

Mesh:

Substances:

Year:  2015        PMID: 26359493      PMCID: PMC4653662          DOI: 10.1074/jbc.M115.678839

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.

Authors:  J A Huntington; S T Olson; B Fan; P G Gettins
Journal:  Biochemistry       Date:  1996-07-02       Impact factor: 3.162

2.  Dramatic enhancement of the catalytic activity of coagulation factor IXa by alcohols.

Authors:  J Sturzebecher; E Kopetzki; W Bode; K P Hopfner
Journal:  FEBS Lett       Date:  1997-07-28       Impact factor: 4.124

3.  The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.

Authors:  B Turk; I Brieditis; S C Bock; S T Olson; I Björk
Journal:  Biochemistry       Date:  1997-06-03       Impact factor: 3.162

4.  Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

Authors:  S T Olson; I Björk; J D Shore
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

5.  Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants.

Authors:  K P Hopfner; H Brandstetter; A Karcher; E Kopetzki; R Huber; R A Engh; W Bode
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

6.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.

Authors:  S T Olson; I Björk; R Sheffer; P A Craig; J D Shore; J Choay
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

Review 7.  Antithrombin and its inherited deficiency states.

Authors:  H H van Boven; D A Lane
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

8.  Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.

Authors:  E Ersdal-Badju; A Lu; X Peng; V Picard; P Zendehrouh; B Turk; I Björk; S T Olson; S C Bock
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Thermodynamics of charged oligopeptide-heparin interactions.

Authors:  D P Mascotti; T M Lohman
Journal:  Biochemistry       Date:  1995-03-07       Impact factor: 3.162

10.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

View more
  2 in total

Review 1.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

2.  Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution.

Authors:  He-Ming Huang; Xin Jiang; Ling-Bing Meng; Chen-Yi Di; Peng Guo; Yong Qiu; Ya-Lun Dai; Xian-Qiang Lv; Chang-Jin Shi
Journal:  J Int Med Res       Date:  2019-07-15       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.